We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+12.01%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.93B
AUM Growth
+$250M
Cap. Flow
-$114M
Cap. Flow %
-2.9%
Top 10 Hldgs %
11.18%
Holding
330
New
36
Increased
50
Reduced
172
Closed
27

Top Buys

Rank Stock Value
1
EEFT icon
Euronet Worldwide
EEFT
+$26.6M
2
ARES icon
Ares Management
ARES
+$23.5M
3
PD icon
PagerDuty
PD
+$19.6M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$15.4M
5
TTD icon
Trade Desk
TTD
+$14.8M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$37.9M
2
CY
Cypress Semiconductor
CY
+$27.5M
3
SCHW
Charles Schwab
SCHW
+$25.3M
4
TECD
Tech Data Corp
TECD
+$19.8M
5
GVA icon
Granite Construction
GVA
+$16.8M

Sector Composition

Rank Sector Weight
1 Technology 21.94%
2 Healthcare 20.73%
3 Financials 15.22%
4 Consumer Discretionary 12.43%
5 Industrials 11.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXNX
101
DELISTED
Axonics, Inc. Common Stock
AXNX
$17M 0.43%
+613,521
New +$14.6M
GTLS
102
DELISTED
Chart Industries
GTLS
$17M 0.43%
251,584
-2,942
-1% -$172K
CME icon
103
CME Group
CME
$94.8B
$16.9M 0.43%
84,225
+323
+0.4% +$66.3K
CIR
104
DELISTED
CIRCOR International, Inc
CIR
$16.9M 0.43%
365,581
-117,055
-24% -$4.84M
ONTO icon
105
Onto Innovation
ONTO
$14.5B
$16.8M 0.43%
461,052
-4,939
-1% -$168K
KNX icon
106
Knight Transportation
KNX
$11.2B
$16.8M 0.43%
469,932
-5,087
-1% -$187K
IRWD icon
107
Ironwood Pharmaceuticals
IRWD
$669M
$16.8M 0.43%
1,259,947
-14,743
-1% -$163K
TFIN icon
108
Triumph Financial Inc
TFIN
$1.8B
$16.8M 0.43%
440,651
-5,138
-1% -$177K
ALXN
109
DELISTED
Alexion Pharmaceuticals
ALXN
$16.5M 0.42%
152,614
+587
+0.4% +$62.8K
VRTS icon
110
Virtus Investment Partners
VRTS
$1.11B
$16.4M 0.42%
134,944
-1,579
-1% -$176K
TRHC
111
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$16.3M 0.42%
335,359
+30,029
+10% +$1.41M
GSHD icon
112
Goosehead Insurance
GSHD
$2.29B
$16.1M 0.41%
380,150
-4,561
-1% -$202K
EBS icon
113
Emergent Biosolutions
EBS
$229M
$16.1M 0.41%
298,045
-3,442
-1% -$187K
ACAD icon
114
Acadia Pharmaceuticals
ACAD
$5.06B
$15.9M 0.41%
371,777
-22,476
-6% -$978K
PCRX icon
115
Pacira BioSciences
PCRX
$974M
$15.2M 0.39%
335,062
-3,902
-1% -$166K
IOVA icon
116
Iovance Biotherapeutics
IOVA
$2.9B
$15M 0.38%
541,976
-101,439
-16% -$2.31M
MNTA
117
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$14.8M 0.38%
750,633
-81,994
-10% -$1.31M
PLCE icon
118
Children's Place
PLCE
$58.3M
$14.8M 0.38%
236,851
-5,001
-2% -$365K
WNC icon
119
Wabash National
WNC
$510M
$14.5M 0.37%
989,513
-10,986
-1% -$163K
IMMU
120
DELISTED
Immunomedics Inc
IMMU
$14.5M 0.37%
686,873
-173,750
-20% -$3.07M
MTZ icon
121
MasTec
MTZ
$21.5B
$14.4M 0.37%
224,780
-519
-0.2% -$34.2K
USCR
122
DELISTED
U S Concrete, Inc.
USCR
$14.3M 0.37%
344,245
-7,264
-2% -$332K
MNRO icon
123
Monro
MNRO
$368M
$13.8M 0.35%
175,930
-46,073
-21% -$3.47M
CDNA icon
124
CareDx
CDNA
$2.44B
$13.7M 0.35%
633,282
+36,943
+6% +$848K
MDRX
125
DELISTED
Veradigm Inc. Common Stock
MDRX
$13.5M 0.34%
1,370,600
-15,797
-1% -$166K
3 4
5
6 7

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return

Peregrine Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Peregrine Capital Management held 330 positions worth $3.93B, up 6.8% from $3.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Peregrine Capital Management's Q4 2019 filing shows 36 new, 50 increased, 172 reduced and 27 closed positions. Its largest new stake was Euronet Worldwide: 176,319 shares worth $27.8M. The largest sale was DexCom, an estimated $37.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q4 2019 buy was Euronet Worldwide: 176,319 shares worth $27.8M.
  • Peregrine Capital Management added most to Focus Financial Partners Inc. Class A in Q4 2019, an estimated $7.51M increase.
  • Peregrine Capital Management's biggest Q4 2019 reduction was DexCom, cutting an estimated $37.9M.
  • Peregrine Capital Management fully exited Cypress Semiconductor in Q4 2019, selling an estimated $27.5M.
  • Peregrine Capital Management's ten largest holdings make up 11% of its $3.93B portfolio in Q4 2019.
  • Peregrine Capital Management opened 36 new positions and closed 27 in Q4 2019.
  • Peregrine Capital Management's portfolio value rose 6.8% quarter-over-quarter to $3.93B.

Based on Peregrine Capital Management's 13F filing for Q4 2019, filed 16 Jan 2020.